Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Heterotopic Ossification in Elbow Surgery
NCT06088407Completed
- Sponsor
- Shamir Medical Center
- Start
- Feb 2016
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid in heterotopic ossification (HO) (2 arms), sponsored by Shamir Medical Center. Primary endpoint: Presence of Heterotopic Ossification in plain radiographs at 1 year. Started Feb 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
heterotopic ossification (HO)
Beyond the preview
Go deeper on NCT06088407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06088407.